July 20, 2007 – Mediware Information Systems announced today that they have completed an agreement under which Mediware will market Neoteric’s BloodTrack transfusion administration and tracking components in North America and integrate these technologies into HCLL, Mediware’s next-generation blood transfusion management system.
Neoteric and Mediware’s agreement will provide hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions with a closed loop environment for transfusion information to increase patient safety practices, lower costs and improve efficiencies and productivity of the entire blood transfusion process.
Neoteric’s blood management products, which will be marketed by Mediware in North America under the BloodSafe brand name, will extend Mediware’s HCLL transfusion management system and reportedly enable better control of blood products within the hospital and ensure that blood is transfused to the right patient following the right procedures at the bedside. This will improve the blood banks’ ability to manage blood inventory while increasing patient safety, according to manufacturer.
For more information: www.neoterictech.com and www.mediware.com